$VTGN
VistaGen Therapeutics Inc
PRICE
$0.159 ▲0.76%
Extented Hours
VOLUME
13,515,392
DAY RANGE
0.1565 - 0.17
52 WEEK
0.1388 - 3.26
Key Metrics
Market Cap
34.41 M
Beta
1.62
Avg. Volume
22.74 M
Shares Outstanding
206.64 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-11
Next Dividend Date
Company Information
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other CNS disorders. Each of VistaGen's three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date, and has therapeutic potential in multiple CNS markets.
Website: www.vistagen.com
HQ: ,
Related News